Literature DB >> 17973384

Understanding cAMP-dependent allostery by NMR spectroscopy: comparative analysis of the EPAC1 cAMP-binding domain in its apo and cAMP-bound states.

Mohammad T Mazhab-Jafari1, Rahul Das, Steven A Fotheringham, Soumita SilDas, Somenath Chowdhury, Giuseppe Melacini.   

Abstract

cAMP (adenosine 3',5'-cyclic monophosphate) is a ubiquitous second messenger that activates a multitude of essential cellular responses. Two key receptors for cAMP in eukaryotes are protein kinase A (PKA) and the exchange protein directly activated by cAMP (EPAC), which is a recently discovered guanine nucleotide exchange factor (GEF) for the small GTPases Rap1 and Rap2. Previous attempts to investigate the mechanism of allosteric activation of eukaryotic cAMP-binding domains (CBDs) at atomic or residue resolution have been hampered by the instability of the apo form, which requires the use of mixed apo/holo systems, that have provided only a partial picture of the CBD apo state and of the allosteric networks controlled by cAMP. Here, we show that, unlike other eukaryotic CBDs, both apo and cAMP-bound states of the EPAC1 CBD are stable under our experimental conditions, providing a unique opportunity to define at an unprecedented level of detail the allosteric interactions linking two critical functional sites of this CBD. These are the phosphate binding cassette (PBC), where cAMP binds, and the N-terminal helical bundle (NTHB), which is the site of the inhibitory interactions between the regulatory and catalytic regions of EPAC. Specifically, the combined analysis of the cAMP-dependent changes in chemical shifts, 2 degrees structure probabilities, hydrogen/hydrogen exchange (H/H) and hydrogen/deuterium exchange (H/D) protection factors reveals that the long-range communication between the PBC and the NTHB is implemented by two distinct intramolecular cAMP-signaling pathways, respectively, mediated by the beta2-beta3 loop and the alpha6 helix. Docking of cAMP into the PBC perturbs the NTHB inner core packing and the helical probabilities of selected NTHB residues. The proposed model is consistent with the allosteric role previously hypothesized for L273 and F300 based on site-directed mutagenesis; however, our data show that such a contact is part of a significantly more extended allosteric network that, unlike PKA, involves a tight coupling between the alpha- and beta-subdomains of the EPAC CBD. The proposed mechanism of allosteric activation will serve as a basis to understand agonism and antagonism in the EPAC system and provides also a general paradigm for how small ligands control protein-protein interfaces.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17973384     DOI: 10.1021/ja0753703

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  23 in total

Review 1.  Solution NMR Spectroscopy for the Study of Enzyme Allostery.

Authors:  George P Lisi; J Patrick Loria
Journal:  Chem Rev       Date:  2016-01-06       Impact factor: 60.622

2.  Dynamically driven ligand selectivity in cyclic nucleotide binding domains.

Authors:  Rahul Das; Somenath Chowdhury; Mohammad T Mazhab-Jafari; Soumita Sildas; Rajeevan Selvaratnam; Giuseppe Melacini
Journal:  J Biol Chem       Date:  2009-04-29       Impact factor: 5.157

3.  Structure-Activity Relationship Studies of Substituted 2-(Isoxazol-3-yl)-2-oxo-N'-phenyl-acetohydrazonoyl Cyanide Analogues: Identification of Potent Exchange Proteins Directly Activated by cAMP (EPAC) Antagonists.

Authors:  Na Ye; Yingmin Zhu; Haijun Chen; Zhiqing Liu; Fang C Mei; Christopher Wild; Haiying Chen; Xiaodong Cheng; Jia Zhou
Journal:  J Med Chem       Date:  2015-07-16       Impact factor: 7.446

4.  Communication between tandem cAMP binding domains in the regulatory subunit of protein kinase A-Ialpha as revealed by domain-silencing mutations.

Authors:  E Tyler McNicholl; Rahul Das; Soumita SilDas; Susan S Taylor; Giuseppe Melacini
Journal:  J Biol Chem       Date:  2010-03-04       Impact factor: 5.157

Review 5.  Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.

Authors:  William G Robichaux; Xiaodong Cheng
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

6.  Mechanism of cAMP Partial Agonism in Protein Kinase G (PKG).

Authors:  Bryan VanSchouwen; Rajeevan Selvaratnam; Rajanish Giri; Robin Lorenz; Friedrich W Herberg; Choel Kim; Giuseppe Melacini
Journal:  J Biol Chem       Date:  2015-09-14       Impact factor: 5.157

Review 7.  Recent advances in the discovery of small molecules targeting exchange proteins directly activated by cAMP (EPAC).

Authors:  Haijun Chen; Christopher Wild; Xiaobin Zhou; Na Ye; Xiaodong Cheng; Jia Zhou
Journal:  J Med Chem       Date:  2013-11-27       Impact factor: 7.446

8.  Role of dynamics in the autoinhibition and activation of the exchange protein directly activated by cyclic AMP (EPAC).

Authors:  Bryan VanSchouwen; Rajeevan Selvaratnam; Federico Fogolari; Giuseppe Melacini
Journal:  J Biol Chem       Date:  2011-08-26       Impact factor: 5.157

Review 9.  EPAC proteins transduce diverse cellular actions of cAMP.

Authors:  Gillian Borland; Brian O Smith; Stephen J Yarwood
Journal:  Br J Pharmacol       Date:  2009-02-06       Impact factor: 8.739

10.  A mechanism for the auto-inhibition of hyperpolarization-activated cyclic nucleotide-gated (HCN) channel opening and its relief by cAMP.

Authors:  Madoka Akimoto; Zaiyong Zhang; Stephen Boulton; Rajeevan Selvaratnam; Bryan VanSchouwen; Melanie Gloyd; Eric A Accili; Oliver F Lange; Giuseppe Melacini
Journal:  J Biol Chem       Date:  2014-05-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.